Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 août 2018 08h00 HE | Source: Kitov Pharma Ltd.

Kitov Pharma Provides Corporate Update and Reports First Half 2018 Financial Results

Tel Aviv, Israel, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company, today provided a corporate update and reported financial results...
30 juil. 2018 07h47 HE | Source: Kitov Pharma Ltd.

Kitov Announces Settlement of Shareholder Class Action Litigation

Tel Aviv, Israel, July 30, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (Nasdaq: KTOV; TASE: KTOV.TA), an innovative biopharmaceutical company, today announced that it has entered into a Stipulation...
27 juin 2018 09h17 HE | Source: Kitov Pharma Ltd.

Kitov to Host Business Update Conference Call on Monday, July 2

Tel Aviv, Israel, June 27, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (Nasdaq: KTOV; TASE: KTOV), an innovative biopharmaceutical company, today announced that it will host a business update...
15 juin 2018 09h31 HE | Source: Kitov Pharma Ltd.

Kitov Announces Positive Pre-clinical Data from NT219 Demonstrating its Dose-Dependent Anti-Tumor Efficacy

Results in PDX model of pancreatic cancer supports planned IND for NT219 Completes acquisition of substantially all minority shares of TyrNovo, June 15, 2018 TEL AVIV, Israel, June 15, 2018 ...
01 juin 2018 08h40 HE | Source: Kitov Pharma Ltd.

Kitov Announces Pricing of $8,150,000 Registered Direct Offering

TEL-AVIV, Israel, June 01, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company, today announced that it has entered into definitive agreements...
31 mai 2018 13h45 HE | Source: Kitov Pharma Ltd.

FDA Approves Kitov’s Consensi™ for Treatment of Osteoarthritis Pain and Hypertension

New drug choice for millions of Americans offers one pill for treatment of osteoarthritis pain with a built-in antihypertensive TEL AVIV, Israel, May 31, 2018 (GLOBE NEWSWIRE) -- Kitov...
11 mai 2018 08h30 HE | Source: Kitov Pharma Ltd.

Kitov Announces Consensi™ Commercialization Agreement for China

Consensi™ PDUFA date of May 31, 2018, Upcoming TEL AVIV, Israel, May 11, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced...